Experiencing stress during sensitive periods of development, especially infancy, is a predisposing factor for various types of psychopathology, including depression, anxiety, schizophrenia, and posttraumatic stress disorder (Cicchetti & Toth, Reference Cicchetti and Toth2005; Teicher et al., Reference Teicher, Andersen, Polcari, Anderson, Navalta and Kim2003). Although some individuals cope successfully and function competently despite significant early-life adversity (Cicchetti & Rogosch, Reference Cicchetti and Rogosch2009), it is more common to see deleterious consequences. The behavioral sequelae of childhood maltreatment include the development of disorganized attachment, trouble with affect regulation, problems with peer relationships, and the presence of numerous psychiatric disorders (Cicchetti & Toth, Reference Cicchetti and Toth1995; Cirulli et al., Reference Cirulli, Francia, Berry, Aloe, Alleva and Suomi2009; Gershon, Sudheimer, Tirouvanziam, Williams, & O'Hara, Reference Gershon, Sudheimer, Tirouvanziam, Williams and O'Hara2013; Lupien, McEwen, Gunnar, & Heim, Reference Lupien, McEwen, Gunnar and Heim2009; Meaney, Reference Meaney2001). In addition, children who are maltreated exhibit a host of biological consequences over time, including altered hypothalamus–pituitary–adrenal axis function (Gunnar, Frenn, Wewerka, & Van Ryzin, Reference Gunnar, Frenn, Wewerka and Van Ryzin2009; Heim et al., Reference Heim, Newport, Heit, Graham, Wilcox, Bonsall and Nemeroff2000, Reference Heim, Newport, Wagner, Wilcox, Miller and Nemeroff2002; Loman & Gunnar, Reference Loman and Gunnar2010), abnormal volume of specific brain regions (Cohen et al., Reference Cohen, Grieve, Hoth, Paul, Sweet, Tate and Williams2006; Vythilingam et al., Reference Vythilingam, Heim, Newport, Miller, Anderson, Bronen and Charney2002), and atypical expression of genes and proteins important in development, plasticity, stress regulation, and inflammation (Carpenter et al., Reference Carpenter, Gawuga, Tyrka, Lee, Anderson and Price2010; Kim-Cohen et al., Reference Kim-Cohen, Caspi, Taylor, Williams, Newcombe, Craig and Moffitt2006; McGowan et al., Reference McGowan, Sasaki, D'Alessio, Dymov, Labonte, Szyf, Turecki and Meaney2009; Mehta et al., Reference Mehta, Klengel, Conneely, Smith, Altmann, Pace and Binder2013).
Preclinical studies using animal models parallel many of the findings in the human literature (for reviews see Blaze & Roth, Reference Blaze and Roth2015; Heim & Nemeroff, Reference Heim and Nemeroff2001; Lutz & Turecki, Reference Lutz and Turecki2014). To model early-life adversity, rodent models have capitalized on low levels of maternal care (Caldji, Diorio, & Meaney, Reference Caldji, Diorio and Meaney2000; Caldji et al., Reference Caldji, Tannenbaum, Sharma, Francis, Plotsky and Meaney1998; Francis, Diorio, Liu, & Meaney, Reference Francis, Diorio, Liu and Meaney1999; Liu et al., Reference Liu, Diorio, Tannenbaum, Caldji, Francis, Freedman and Meaney1997; Weaver et al., Reference Weaver, Cervoni, Champagne, D'Alessio, Sharma, Seckl and Meaney2004), maternal separation (Boku et al., Reference Boku, Toda, Nakagawa, Kato, Inoue, Koyama and Kusumi2015; Braun, Lange, Metzger, & Poeggel, Reference Braun, Lange, Metzger and Poeggel1999; Chocyk et al., Reference Chocyk, Bobula, Dudys, Przyborowska, Majcher-Maślanka, Hess and Wędzony2013; Franklin et al., Reference Franklin, Russig, Weiss, Graff, Linder, Michalon, Vizi and Mansuy2010; Kundakovic, Lim, Gudsnuk, & Champagne, Reference Kundakovic, Lim, Gudsnuk and Champagne2013; Monroy, Hernández-Torres, & Flores, Reference Monroy, Hernández-Torres and Flores2010; Muhammad, Carroll, & Kolb, Reference Muhammad, Carroll and Kolb2012; Uchida et al., Reference Uchida, Hara, Kobayashi, Funato, Hobara, Otsuki and Watanabe2010; Wang et al., Reference Wang, Nie, Li, Hou, Yu, Fan and Sun2014; Weiss, Franklin, Vizi, & Menaey, Reference Weiss, Franklin, Vizi and Mansuy2011; Zhang, Qin, & Zhao, Reference Zhang, Qin and Zhao2013), or experimentally manipulated exposure to painful stimuli or caregiver maltreatment (Blaze, Scheuing, & Roth, Reference Blaze, Scheuing and Roth2013; Chen et al., Reference Chen, Rex, Rice, Dubé, Gall, Lynch and Baram2010; Ivy, Brunson, Sandman, & Baram, Reference Ivy, Brunson, Sandman and Baram2008; Ivy et al., Reference Ivy, Rex, Chen, Dubé, Maras, Grigoriadis and Baram2010; Moriceau, Shinoya, Jakubs, & Sullivan, Reference Moriceau, Shionoya, Jakubs and Sullivan2009; Roth, Lubin, Funk, & Sweatt, Reference Roth, Lubin, Funk and Sweatt2009; Roth & Sullivan, Reference Roth and Sullivan2005). All of these models have shown behavioral and neurobiological alterations reminiscent of those in humans.
One way that stress may lead to neurobiological and behavioral deficits is through epigenetic modifications such as DNA methylation. DNA methylation is a chemical modification to chromatin in which a methyl group is added to DNA, a reaction that normally suppresses gene transcription. Evidence has also shown DNA methylation to have activational effects on gene transcription, although less is known about this phenomenon (Chahrour et al., Reference Chahrour, Jung, Shaw, Zhou, Wong, Qin and Zoghbi2008). Data continue to accumulate showing that early-life maltreatment produces changes in DNA methylation in the brain and periphery of both humans and animals (for recent reviews, see (Blaze & Roth, Reference Blaze and Roth2015; Lutz & Turecki, Reference Lutz and Turecki2014). Our lab has provided substantial evidence of altered brain-derived neurotrophic factor (Bdnf) methylation in the rat brain following exposure to caregiver maltreatment (Blaze, Asok, & Roth, Reference Blaze, Asok and Roth2015; Blaze & Roth, Reference Blaze and Roth2013; Blaze et al., Reference Blaze, Scheuing and Roth2013; Roth et al., Reference Roth, Lubin, Funk and Sweatt2009; Roth, Matt, Chen, & Blaze, Reference Roth, Matt, Chen and Blaze2014). The Bdnf gene codes for a protein (BDNF) that is crucial for neurodevelopment and implicated in learning and memory processes as well as many psychiatric disorders (Martinowich, Manji, & Lu, Reference Martinowich, Manji and Lu2007; Monteggia et al., Reference Monteggia, Luikart, Barrot, Theobold, Malkovska, Nef and Nestler2007). Changes in Bdnf methylation following early-life stress in our rodent model include an increase in methylation in the whole prefrontal cortex (PFC; Roth et al., Reference Roth, Lubin, Funk and Sweatt2009) as well as within the medial PFC (mPFC; Blaze et al., Reference Blaze, Scheuing and Roth2013, Reference Blaze, Asok and Roth2015).
Multiple studies have emerged in recent years suggesting that DNA methylation patterns differ between neurons and nonneurons for multiple gene loci in the human (Guintivano, Aryee, & Kaminsky, Reference Guintivano, Aryee and Kaminsky2013; Iwamoto et al., Reference Iwamoto, Bundo, Ueda, Oldham, Ukai, Hashimoto and Kato2011; Kozlenkov et al., Reference Kozlenkov, Roussos, Timashpolsky, Barbu, Rudchenko, Bibikova and Di Narzo2014; Lister et al., Reference Lister, Mukamel, Nery, Urich, Puddifoot, Johnson and Ecker2013; Nishioka et al., Reference Nishioka, Shimada, Bundo, Ukai, Hashimoto, Saito and Iwamoto2013) and rodent (Li, Baker-Andresen, Zhao, Marshall, & Bredy, Reference Li, Baker-Andresen, Zhao, Marshall and Bredy2014; Lister et al., Reference Lister, Mukamel, Nery, Urich, Puddifoot, Johnson and Ecker2013; Nishioka et al., Reference Nishioka, Shimada, Bundo, Ukai, Hashimoto, Saito and Iwamoto2013) PFC. For example, Li et al. (Reference Li, Baker-Andresen, Zhao, Marshall and Bredy2014) recently showed that rodent ventromedial PFC neurons display greater global DNA methylation compared to nonneurons. Our previous work utilized a homogenate of brain tissue for downstream methylation analysis, thus providing an estimate of methylation across the heterogeneous cell populations within the tissue. Because at least one-third of cells in the PFC are glia (including astrocytes, oligodendrocytes, and microglia; Azevedo et al., Reference Azevedo, Carvalho, Grinberg, Farfel, Ferretti, Leite and Herculano-Houzel2009; Guintivano et al., Reference Guintivano, Aryee and Kaminsky2013), and because all central nervous system cell types express Bdnf at some level (Aid, Kazantseva, Piirsoo, Palm, & Timmusk, Reference Aid, Kazantseva, Piirsoo, Palm and Timmusk2007; Nakajima & Kohsaka, Reference Nakajima and Kohsaka2001; Riley, Cope, & Buck, Reference Riley, Cope and Buck2004; Wei, Lin, & Tu, Reference Wei, Lin and Tu2010), it poses the question of in which cell type are our maltreatment-induced Bdnf methylation changes occurring.
To build upon our previous research, the current study aimed to determine if maltreatment-induced Bdnf DNA methylation patterns differ for neurons and nonneurons. Previously, we found sex- and treatment-specific changes in the adult (postnatal day 90 [PN90]) mPFC in a heterogeneous population of cells (Blaze et al., Reference Blaze, Scheuing and Roth2013, Reference Blaze, Asok and Roth2015). In the current study, we used fluorescence-activated cell sorting to isolate neurons and nonneurons (glia) from the mPFC of adult (PN90) male and female rats that experienced early-life caregiver maltreatment or nurturing care and measured DNA methylation of Bdnf IV.
Methods
Animals
For this study, subjects were 62 adult (PN90) male and female outbred Long–Evans rats that experienced our caregiver manipulations during infancy (9–11/sex/condition). These animals were obtained from our in-house breeding colony and maintained in a temperature-controlled (range = 20 ± 1 °C) and light-controlled colony room (12-hr light/12-hr dark cycle with lights on at 6:00 a.m.) with ad libitum access to food and water. For breeding in our colony, one male and one female rat (obtained from Harlan) were placed together in a wire-bottomed cage and separated once a sperm plug was detected (indicating successful copulation). Pregnant females were housed alone in standard cages with plentiful wood shavings and ad libitum access to food and water. The day of birth was indicated as PN0 and pups were culled to 5–6 males and 5–6 females before caregiving manipulations took place on PN1–7. No first-time mothers were used as experimental or stimulus caregivers. All procedures were approved by the University of Delaware Animal Care and Use Committee.
Early-life caregiving paradigm
We performed caregiving manipulations using a well-established protocol previously reported in our laboratory (Asok, Bernard, Rosen, Dozier, & Roth, Reference Asok, Bernard, Rosen, Dozier and Roth2014; Blaze et al., Reference Blaze, Scheuing and Roth2013, Reference Blaze, Asok and Roth2015; Blaze & Roth, Reference Blaze and Roth2013; Roth et al., Reference Roth, Lubin, Funk and Sweatt2009, Reference Roth, Matt, Chen and Blaze2014) and adapted from others (Ivy et al., Reference Ivy, Brunson, Sandman and Baram2008; Roth & Sullivan, Reference Roth and Sullivan2005). On PN1, each experimental litter was separated into three groups of 2 male and 2 female pups and marked numerically with nontoxic permanent marker for identification. During experimental manipulations, which were conducted at different, unpredictable times every day from PN1 to 7, pups in the maltreatment and cross-foster care conditions were transported to a room and placed with another lactating dam for 30 min (matched for postpartum age and diet to the biological mom). The maltreatment group experienced a dam that had been placed in the chamber with no time to habituate and minimal nesting resources (i.e., wood chip bedding). The cross-foster care group experienced a dam (also matched for postpartum age and diet to the biological mom) that had been given 1 hr to habituate in her chamber and was provided with ample nesting resources to care for the pups. The normal care condition was left with the biological mother in the home cage during the 30-min sessions. After exposures, pups were returned to the biological mother until the following day's session. After PN7, litters were left undisturbed until weaning at PN21–23 and then housed with a same-sex, same-condition littermate until PN90.
Caregiving behaviors directed toward pups were scored by trained observers via live observation and/or video recordings. Behavioral data were collected by tallying nurturing and aversive caregiving behaviors in 5-min time-bins during the 30-min sessions. Scores were then averaged across all seven exposure days. Ultrasonic and audible vocalizations from pups were also scored, and these measures were collected with a bat detector (40 kHz; Batbox III, NHBS Ltd., UK) and audible voice recorder during each session. Vocalizations were coded by trained observers who tallied the presence of an ultrasonic or audible vocalization in each minute of the 30-min session, and these data were likewise averaged across the seven exposure sessions.
Tissue collection
Brains were collected at PN90 via rapid decapitation at baseline conditions (i.e., with minimal disturbance/stimulation to animals when removing them from their home cage) following light isoflurane anesthesia. After removal, brains were immediately sliced into 1-mm coronal sections using a brain matrix and flash frozen with 2-methylbutane on untreated slides. Slides were frozen at –80 °C until later processing. In addition, postmortem vaginal lavages were performed to determine estrous cycle stage for all females.
Fluorescence-activated cell sorting (FACS)
To isolate neurons and nonneurons, we used a technique created by the Akbarian lab (Matevossian & Akbarian, Reference Matevossian and Akbarian2008) and adapted for rodents by the Bredy lab (Li et al., Reference Li, Baker-Andresen, Zhao, Marshall and Bredy2014; depicted in Figure 1). The mPFC was dissected on dry ice and placed immediately in nuclear extraction buffer (0.32 M sucrose, 10 mM Tris HCl, 5 mM CaCl2, 3 mM Mg(C2H3O2)2, 0.1 mM EDTA, 1 mM dithiothreitol, 0.1% Triton-X-100, and Halt Protease Inhibitor Cocktail), homogenized, and filtered through a 40-μm cell strainer. After centrifugation, nuclei were resuspended and incubated for 1 hr with staining mixtures. To isolate neurons with immunostaining, we used an antibody specific to NeuN (1:1200, Millipore) along with the secondary antibody Alexafluor 488 (1:700, Life Technologies Corp.). We also stained with DAPI to identify nuclei versus debris. After staining, samples were transported on ice to the Helen F. Graham Cancer Center at Christiana Hospital, where they were sorted into two populations (DAPI+/NeuN+ and DAPI+/NeuN–) with the FACSAria II Flow Cytometer. For each sample, we also had an unstained control that was run prior to the DAPI/NeuN stained sample to control for background. Cells were sorted in 1X PBS, stored on ice for 30–60 min during transport back to the lab, and DNA was extracted immediately using the Quick-gDNA MicroPrep kit (Zymo) according to the manufacturer's protocol. Concentration and purity of DNA was determined using a Nanodrop spectrophotometer.
DNA methylation assays
After FACS, we used direct bisulfite sequencing polymerase chain reactions (BSP) to measure Bdnf IV methylation in mPFC tissue of adult rats that experienced our caregiver manipulations. This gene has been well characterized in rodent and human studies and consists of nine noncoding exons that each splice to the common coding exon IX (Aid et al., Reference Aid, Kazantseva, Piirsoo, Palm and Timmusk2007). BSP is a technique used previously in our lab (Roth et al., Reference Roth, Lubin, Funk and Sweatt2009, Reference Roth, Matt, Chen and Blaze2014) to estimate methylation at individual cytosine sites of DNA associated with Bdnf IV. Following established protocols (Parrish, Day, & Lubin, Reference Parrish, Day and Lubin2012; Roth et al., Reference Roth, Lubin, Funk and Sweatt2009, Reference Roth, Matt, Chen and Blaze2014; Roth, Zoladz, Sweatt, & Diamond, Reference Roth, Zoladz, Sweatt and Diamond2011), BSP was performed on PN90 bisulfite-treated DNA (Epitect Bisulfite Kit, Qiagen) using primers specific to Bdnf IV (for primer sequences, see Lubin, Roth, & Sweatt, Reference Lubin, Roth and Sweatt2008; Roth et al., Reference Roth, Lubin, Funk and Sweatt2009), and samples were sent to the University of Delaware Sequencing and Genotyping Center for direct bisulfite sequencing using the reverse primer. Methylation for each sample was measured using Chromas software. We confirmed the accuracy of this technique by assessing methylated standards (Rat Pre-mixed Calibration Standards, Epigendx) ranging from 0% to 100% methylation and performing a linear regression on methylation values, F (1, 38) = 214.3, p < .001, R 2 = .8494.
Statistical analyses
Caregiver behaviors and pup vocalizations were analyzed with one- and two-way analyses of variance (ANOVAs) with post hoc tests when appropriate (unpaired t tests or multiple t tests with Bonferonni correction). For both neurons and nonneurons, BSP data were analyzed with two-way ANOVAs comparing average methylation (across all 12 sites) between treatment group and sex (3 × 2), with post hoc tests when necessary (e.g., multiple t tests with Bonferroni correction). In addition, two-way ANOVAs (with multiple t tests with Bonferonni correction) were performed on each of the 12 cytosine–guanine (CG) sites for males and females in both the neuronal and nonneuronal populations. Postmortem vaginal lavages were performed to determine estrous cycle stage for all females. We determined estrus cycle stage by assessing the presence and proportions of leukocytes, nucleated epithelial cells, and/or cornified cells (Bianchi & Tanno, Reference Bianchi and Tanno2001; Caligioni, Reference Caligioni2009). Due to low sample numbers in certain stages of cycling, we combined metestrus/diestrus and proestrus/estrus for analyses, as done by others (Trainor et al., Reference Trainor, Pride, Landeros, Knoblauch, Takahashi, Silva and Crean2011). Two-way ANOVAs for average methylation and at each individual CG site revealed no significant effect of estrous cycle stage, pup treatment, or an interaction (all ps > .05). Moreover, average methylation levels were consistent across all estrous cycle stages (all ps > .05).
Results
Caregiving behavior and pup vocalizations
We observed caregiver behaviors and pup vocalizations during our 30-min sessions on PN1–7 to confirm that maltreated pups were experiencing an adverse caregiving environment. We used a two-way ANOVA to analyze pup condition (normal care, cross-foster care, or maltreatment) and overall caregiver behavior (aversive or nurturing) and found a significant effect of caregiver behavior, F (2, 36) = 67.73, p < .001, and a Pup Condition × Caregiver Behavior interaction, F (2, 36) = 30.08, p < .001. Specifically, dams in the maltreatment condition showed significantly more aversive behaviors and less nurturing behaviors toward pups in comparison to dams in the normal care and cross-foster care conditions (Figure 2). Their aversive behaviors included frequent stepping on, dragging, dropping, active avoidance, and roughly handling of pups (Figure 3).
We also measured audible and ultrasonic vocalizations from pups during our manipulations and averaged values across all seven days. There was a significant effect of pup condition on both audible, F (2, 18) = 5.019, p < .05, and ultrasonic, F (2, 18) = 6.132, p < .01, vocalizations during exposure sessions (Figure 4). Specifically, maltreated pups emitted more audible vocalizations than pups in the cross-foster, marginal effect: t (18) = 2.419, p = .079, and normal care, t (18) = 2.981, p < .05, conditions (Figure 4a). The maltreatment group also emitted significantly more ultrasonic vocalizations compared to the cross-foster, t (18) = 2.742, p < .05, and normal care, t (18) = 3.258, p < .05, conditions (Figure 4b). Together, behavioral results indicate that pups in our maltreatment condition experienced an adverse caregiving environment while pups in our control conditions (cross-foster care and normal care) experienced a nurturing caregiving environment. These observations are consistent with those in our prior reports (Blaze et al., Reference Blaze, Scheuing and Roth2013, Reference Blaze, Asok and Roth2015; Blaze & Roth, Reference Blaze and Roth2013; Roth et al., Reference Roth, Lubin, Funk and Sweatt2009, Reference Roth, Matt, Chen and Blaze2014).
FACS analysis
We used FACS to identify and separate neurons and nonneurons in mPFC brain samples from rats that had undergone our caregiver manipulations. Figure 5 depicts a representative set of scatterplots from a sorted sample. Unstained control samples were run for each sample and yielded minimal to no background. The gate for DAPI+ events, or nuclei, was used as the parent population for further delineation into the NeuN+ and NeuN– populations. The population of NeuN+ (neuronal) nuclei and the population of NeuN– (nonneuronal) nuclei were separated in order to avoid cross-contamination of opposing cell type in our sorted populations of nuclei (5.7% of DAPI+ nuclei). The NeuN+ (neuronal) population of nuclei was significantly larger than the NeuN– (nonneuronal) population of nuclei, with an average of 61% NeuN+ nuclei and ~32% NeuN– nuclei, t (110) = 18.84, p < .001 (Figure 6), which is in line with previous reports of cell composition in the mPFC (Li et al., Reference Li, Baker-Andresen, Zhao, Marshall and Bredy2014; Willing, Kim, Brodsky, Cortes, & Juraska, Reference Willing, Kim, Brodsky, Cortes and Juraska2014).
Neuronal DNA methylation
We used BSP to measure DNA methylation of Bdnf IV in the neuronal and nonneuronal cell populations produced after FACS. A two-way ANOVA, 2 (sex) × 3 (pup treatment), of average methylation percentages (across all CG sites) revealed no effect of sex, F (2, 55) = 0.3841, p = .54, or treatment, F (2, 55) = 1.553, p = .22, alone, but there was a significant interaction of early-life caregiving experience and sex, F (2, 55) = 7.235, p < .01 (Figure 7). Bonferonni-corrected t tests showed more methylation in maltreated females in comparison to normal care females, t (55) = 3.539, p < .05, cross-foster care females, t (55) = 3.035, p = .055, and maltreated males, t (55) = 3.431, p < .05.
To identify any sex- or treatment-specific effects at individual CG sites, we ran two-way ANOVAs, 2 (sex) × 3 (treatment), for each of the 12 CG sites (Figure 8). There was an interaction of sex and pup treatment at CG site 3, F (2, 55) = 3.654, p < .05, site 4, F (2, 55) = 6.789, p < .01, site 5, F (2, 55) = 3.857, p < .05, site 6, F (2, 55) = 3.660, p < .05, site 11, F (2, 55) = 5.924, p < .01, and site 12, F (2, 38) = 3.499, p < .05. Multiple t tests with Bonferroni correction at these sites revealed no effect of treatment on males (Figure 8a; ps > .05), but maltreated females had greater methylation in comparison to normal controls at site 4, t (55) = 3.895, p < .01, site 5, t (55) = 3.076, p < .05, and site 6, t (55) = 3.149, p < .05 (Figure 8b). Further, maltreated females had higher methylation levels at site 4 compared to cross-foster females, t (55) = 3.326, p < .05, and at site 4, t (55) = 3.228, p < .05, and site 6, t (55) = 3.304, p < .05, and site 11, t (55) = 3.243, p < .05, compared to maltreated males.
Nonneuronal DNA methylation
We likewise used BSP to measure methylation of nonneurons in the mPFC of rats that experienced our caregiving manipulations in infancy. Average methylation (across all 12 sites) did not differ between sexes, F (2, 46) = 0.6649, p = .42, pup treatment group, F (2, 46) = 0.2798, p = .76, nor was methylation affected by an interaction between sex and pup treatment group, F (2, 46) = 0.6384, p = .64 (Figure 9). Further, methylation at individual CG sites was not affected by sex, pup treatment, or their interaction (all ps > .05; Figure 10).
Discussion
In the current study, we aimed to characterize methylation of DNA associated with Bdnf IV in mPFC neurons and nonneurons from adult rats with a history of maltreatment. We previously showed that in adult females, maltreatment during infancy yields greater Bdnf IV methylation in the mPFC (Blaze et al., Reference Blaze, Scheuing and Roth2013, Reference Blaze, Asok and Roth2015). In these prior studies, data were generated from a heterogeneous mix of cells from mPFC tissue, not controlling for cell type. Recent work has shown evidence of cell-type specific DNA methylation patterns in neurons versus glia (Li et al., Reference Li, Baker-Andresen, Zhao, Marshall and Bredy2014; Lister et al., Reference Lister, Mukamel, Nery, Urich, Puddifoot, Johnson and Ecker2013), and altered Bdnf methylation of these cell types may have different downstream consequences for brain function and behavior (Martinowich et al., Reference Martinowich, Manji and Lu2007; Wei et al., Reference Wei, Lin and Tu2010). To investigate the effects of maltreatment on methylation within specific cell types here, we used FACS to isolate neuronal and nonneuronal cell populations from mPFC tissue before measuring Bdnf IV DNA methylation.
First, FACS data revealed that about 60% of nuclei in our mPFC samples were neurons, while the rest were glia. Other groups have published similar data consistent with our neuron:glia ratio for the mPFC (Li et al., Reference Li, Baker-Andresen, Zhao, Marshall and Bredy2014; Willing et al., Reference Willing, Kim, Brodsky, Cortes and Juraska2014). Second, FACS data revealed that maltreated females had higher levels of neuronal methylation in comparison to female controls and maltreated males. Site-specific neuronal methylation for maltreated females was also highest at CG sites 4, 5, and 6. Moreover, we showed that Bdnf IV methylation was unrelated to stage of estrous cycle in these animals, which was unknown in our previous study (Blaze et al., Reference Blaze, Scheuing and Roth2013). Third, when we examined methylation in nonneurons after FACS, we found no changes in average or site-specific Bdnf IV methylation in our maltreated male or maltreated female rats. In all, our Bdnf neuronal methylation patterns paralleled those previously observed for bulk mPFC tissue (Blaze et al., Reference Blaze, Scheuing and Roth2013, Reference Blaze, Asok and Roth2015). Due to the prevalence of Bdnf in neurons compared to glia (Kawamoto, Nakamura, Kawamata, Akiguci, & Kimura, Reference Kawamoto, Nakamura, Kawamata, Akiguchi and Kimura1999; Martinowich et al., Reference Martinowich, Hattori, Wu, Fouse, He, Hu and Sun2003), it appears that maltreatment-induced changes are taking place where most Bdnf is located.
Sex differences in behavioral, cellular, and molecular responses to early-life experiences have consistently been reported (for reviews, see Bale & Epperson, Reference Bale and Epperson2015; Bock, Rether, Groeger, Xie, & Braun, Reference Bock, Rether, Groeger, Xie and Braun2014; McEwen, Reference McEwen2010; Teicher et al., Reference Teicher, Andersen, Polcari, Anderson, Navalta and Kim2003). Here we found greater Bdnf IV DNA methylation in the mPFC of female rats. This is an observation we have reported in other studies (Blaze et al., Reference Blaze, Scheuing and Roth2013, Reference Blaze, Asok and Roth2015) and is consistent with other sex-specific epigenetic effects that continue to emerge in the study of early adversity (e.g., Cicchetti, Rogosch, Hecht, Cick, & Hetzel, Reference Cicchetti, Rogosch, Hecht, Crick and Hetzel2014; Essex et al., Reference Essex, Thomas Boyce, Hertzman, Lam, Armstrong, Neumann and Kobor2013; Franklin et al., Reference Franklin, Russig, Weiss, Graff, Linder, Michalon, Vizi and Mansuy2010; Kundakovic et al., Reference Kundakovic, Lim, Gudsnuk and Champagne2013; Melas et al., Reference Melas, Wei, Wong, Sjöholm, Åberg, Mill, Schalling and Lavebratt2013; Mueller & Bale, Reference Mueller and Bale2008; St.-Cyr & McGowan, Reference St.-Cyr and McGowan2015). As DNA methylation is sexually dimorphic in the developing brain (Kigar, Chang, Hayne, Kala, & Auger, Reference Kigar, Chang, Hayne, Karls and Auger2016; Kolodkin & Auger, Reference Kolodkin and Auger2011; McCarthy et al., Reference McCarthy, Auger, Bale, De Vries, Dunn, Forger and Wilson2009; Nugent & McCarthy, Reference Nugent and McCarthy2011; Nugent et al., Reference Nugent, Wright, Shetty, Hodes, Lenz, Mahurkar and McCarthy2015; Spiers et al., Reference Spiers, Hannon, Schalkwyk, Smith, Wong, O'Donovan and Mill2015), this likely plays some role in the differential sensitivity to and/or outcomes associated with maltreatment we have observed in male and female rats here and in our other studies (Blaze et al., Reference Blaze, Scheuing and Roth2013, Reference Blaze, Asok and Roth2015; Blaze & Roth, Reference Blaze and Roth2013; Roth et al., Reference Roth, Matt, Chen and Blaze2014). In addition, it is known that within the nest, dams spend less time nursing and licking female pups (Hao, Huang, Nielsen, & Kosten, Reference Hao, Huang, Nielsen and Kosten2011; Moore & Morelli, Reference Moore and Morelli1979). Due to limitations in our experimental setup, we were unable to identify caregiving behaviors directed toward individual pups, but it is certainly plausible that differential care toward males and females both within our experimental chambers or within the home cage is another contributing factor to the sex differences we observed. We acknowledge the long-term behavioral and health consequences of maltreatment in humans is not limited to females (e.g., Dube et al., Reference Dube, Anda, Whitfield, Brown, Felitti, Dong and Giles2005; Teicher & Samson, Reference Teicher and Samson2016; Thompson, Kingree, & Desai, Reference Thompson, Kingree and Desai2004); thus, we predict that though we did not detect any changes in methylation at this one gene locus in maltreated males, they have other loci with aberrant methylation.
Many studies have demonstrated the deleterious effects of early-life stress on the structure and function of neurons. For example, rat pups that receive low levels of maternal care or maternal deprivation exhibit impairments in measures of dendritic complexity and synaptic plasticity in the adult hippocampus and PFC (Bagot et al., Reference Bagot, van Hasselt, Champagne, Meaney, Krugers and Joëls2009; Chocyk et al., Reference Chocyk, Bobula, Dudys, Przyborowska, Majcher-Maślanka, Hess and Wędzony2013; Monroy et al., Reference Monroy, Hernández-Torres and Flores2010; Pascual & Zamora-Leon, Reference Pascual and Zamora-Leon2007). Further, maternally deprived rats show impairments in hippocampal neurogenesis in response to a later stress challenge (Mirescu, Peters, & Gould, Reference Mirescu, Peters and Gould2004). While neuronal-specific effects of early-life stress are abundant in the literature, only few changes to glia have been reported (Bolton et al., Reference Bolton, Huff, Smith, Mason, Foster, Auten and Bilbo2013; Leventopoulos et al., Reference Leventopoulos, Rüedi-Bettschen, Knuesel, Feldon, Pryce and Opacka-Juffry2007). Glial-specific effects of early-life stress include altered production of pro-inflammatory cytokines from microglia following pre- and early-postnatal stress (Bolton et al., Reference Bolton, Huff, Smith, Mason, Foster, Auten and Bilbo2013) and a reduction in astrocyte density following maternal deprivation during infancy (Leventopoulos et al., Reference Leventopoulos, Rüedi-Bettschen, Knuesel, Feldon, Pryce and Opacka-Juffry2007).
In neurons, Bdnf is upregulated following neuronal activity (Lubin et al., Reference Lubin, Roth and Sweatt2008; Martinowich et al., Reference Martinowich, Hattori, Wu, Fouse, He, Hu and Sun2003) and commonly related to synaptic plasticity, memory, and mood (Martinowich et al., Reference Martinowich, Manji and Lu2007; Nakajima et al., Reference Nakajima, Honda, Tohyama, Imai, Kohsaka and Kurihara2001; Nakajima & Kohsaka, Reference Nakajima and Kohsaka2001). Animals with decreased Bdnf levels show impairments in long-term potentiation and hippocampal-dependent memory (Monteggia et al., Reference Monteggia, Barrot, Powell, Berton, Galanis, Gemelli and Nestler2004) along with abnormal cortical dendrite structure (Gorski, Zailer, Tamowski, & Jones, Reference Gorski, Zeiler, Tamowski and Jones2003) and impaired neurogenesis (Lee, Duan, & Mattson, Reference Lee, Duan and Mattson2002). Altered Bdnf functioning is thus likely one of the mechanisms by which early-life stress could produce abnormalities in neural structure and function, and our data here highlight that DNA methylation could be involved in this process.
Neurons and glia are known to work in tandem to regulate brain function in response to environmental stimuli by secreting BDNF protein, providing support for cells of the brain in times of stress or environmental insult (Coull et al., Reference Coull, Beggs, Boudreau, Boivin, Tsuda, Inoue and De Koninck2005; Nakajima & Kohsaka, Reference Nakajima and Kohsaka2001; Wu et al., Reference Wu, Chen, Dallas, Wilson, Block, Wang and Hong2008). Although glia and neurons express Bdnf and its receptor TrkB in the PFC, its neurotrophic effects can differ across cell types and time points. For example, Bdnf mRNA and protein in astrocytes and microglia are quickly upregulated in response to physical injury (Wei et al., Reference Wei, Lin and Tu2010) or an immune challenge (Nakajima et al., Reference Nakajima, Honda, Tohyama, Imai, Kohsaka and Kurihara2001), playing roles in neuroprotection. Neuronal levels of Bdnf mRNA following stress are sensitive to time course, such that an acute, short stressor (i.e., 60 min immobilization) increases Bdnf mRNA, but repeated stress decreases Bdnf mRNA (Alleva & Santucci, Reference Alleva and Santucci2001; Bilbo et al., Reference Bilbo, Barrientos, Eads, Northcutt, Watkins, Rudy and Maier2008; Marmigère, Givalois, Rage, Arancibia, & Tapia-Arancibia, Reference Marmigère, Givalois, Rage, Arancibia and Tapia-Arancibia2003; Rasmusson, Shi, & Duman, Reference Rasmusson, Shi and Duman2002). Here we only measured DNA methylation at one time point (adulthood, about 3 months past our experimental manipulations); thus, it is possible that Bdnf methylation patterns in neurons and glia would be different at a time point closer to the insult and earlier in development.
Clinical studies have recently begun to delve into the translational aspects of DNA methylation induced by early-life stress (Keller, Sarchiapone, & Zarrilli, Reference Keller, Sarchiapone and Zarrilli2010; McGowan et al., Reference McGowan, Sasaki, D'Alessio, Dymov, Labonte, Szyf, Turecki and Meaney2009; Naumova et al., Reference Naumova, Lee, Koposov, Szyf, Dozier and Grigorenko2012; Oberlander et al., Reference Oberlander, Weinberg, Papsdorf, Grunau, Misri and Devlin2008; Perroud et al., Reference Perroud, Paoloni-Giacobino, Prada, Olie, Salzmann, Nicastro and Malafosse2011; Tyrka, Price, Marsit, Walters, & Carpenter, Reference Tyrka, Price, Marsit, Walters and Carpenter2012; Unternaehrer et al., Reference Unternaehrer, Meyer, Burkhardt, Dempster, Staehli, Theill and Meinlschmidt2015). For Bdnf, it has been shown that borderline personality disorder patients that experienced childhood trauma have higher levels of methylation in peripheral blood leukocytes (Perroud et al., Reference Perroud, Salzmann, Prada, Nicastro, Hoeppli, Furrer and Malafosse2013; Prados et al., Reference Prados, Stenz, Courtet, Prada, Nicastro, Adouan and Perroud2015). Another study found that adults who experienced childhood maltreatment also showed increased methylation of Bdnf DNA in whole blood (Unternaehrer et al., Reference Unternaehrer, Meyer, Burkhardt, Dempster, Staehli, Theill and Meinlschmidt2015). These findings are consistent with our observations of maltreatment-induced increases in central nervous system Bdnf methylation (Blaze et al., Reference Blaze, Scheuing and Roth2013, Reference Blaze, Asok and Roth2015; Roth et al., Reference Roth, Lubin, Funk and Sweatt2009). Further, increased Bdnf methylation has also been associated with depression (Fuchikami et al., Reference Fuchikami, Morinobu, Segawa, Okamoto, Yamawaki, Ozaki and Terao2011; Song et al., Reference Song, Miyaki, Suzuki, Sasaki, Tsutsumi, Kawakami and Kan2014) and schizophrenia (Ikegame et al., Reference Ikegame, Bundo, Sunaga, Asai, Nishimura, Yoshikawa and Iwamoto2013).
Nevertheless, there is increasing evidence that normalizing Bdnf methylation patterns may be a mechanism by which pharmacological or psychological therapy exert their beneficial effects on patients (Chen, Ernst, & Turecki, Reference Chen, Ernst and Turecki2011; Perroud et al., Reference Perroud, Salzmann, Prada, Nicastro, Hoeppli, Furrer and Malafosse2013). For example, postmortem PFC samples (Chen et al., Reference Chen, Ernst and Turecki2011) and blood (Lopez et al., Reference Lopez, Mamdani, Labonte, Beaulieu, Yang, Berlim and Turecki2013) from depressed patients displayed higher Bdnf IV mRNA levels after treatment with antidepressants, which corresponded to a decrease in histone methylation at H3K27 (a repressive epigenetic marker). In addition, bipolar patients undergoing dialectical behavioral therapy displayed decreased Bdnf methylation over time if they were responding to treatment (Perroud et al., Reference Perroud, Salzmann, Prada, Nicastro, Hoeppli, Furrer and Malafosse2013). The concordance between brain and blood or saliva methylation patterns is still largely unknown, but recent studies have shown correlations between blood or saliva and brain methylation for certain genes (Ewald et al., Reference Ewald, Wand, Seifuddin, Yang, Tamashiro, Potash and Lee2014; Walton et al., Reference Walton, Hass, Liu, Roffman, Bernardoni, Roessner and Ehrlich2016), including DNA associated with Bdnf (Smith et al., Reference Smith, Kilaru, Klengel, Mercer, Bradley, Conneely and Binder2015; Stenz et al., Reference Stenz, Zewdie, Laforge-Escarra, Prados, La Harpe, Dayer and Aubry2015). While the search for biomarkers that can be used in the clinic is ongoing, epigenetic studies continue to highlight the utility of Bdnf methylation as a strong candidate.
We acknowledge several limitations of the current study. Technical limitations of tissue processing for FACS prevented us from retrieving RNA, so we were unable to measure gene expression for these animals. We also sorted populations of cells based on the presence of NeuN, and all NeuN– nuclei were a mixture of glia, containing oligodendrocytes, microglia, and astrocytes. We were thus unable to further separate this population to identify if Bdnf methylation was altered in certain glial subtypes, and some studies have shown distinct methylation patterns within glial subtypes for certain gene loci (Perisic et al., Reference Perisic, Zimmermann, Kirmeier, Asmus, Tuorto, Uhr and Zschocke2010; Schwarz, Hutchinson, & Bilbo, Reference Schwarz, Hutchinson and Bilbo2011). Finally, a limitation of the current bisulfite conversion technique used here is the lack of differentiation between 5-methylcytosine and 5-hydroxymethylcytosine. Because these two marks may have different effects on transcription and behavior (Sun, Zang, Shu, & Li, Reference Sun, Zang, Shu and Li2014), it would be useful in the future to use another technique, such as oxidative bisulfite sequencing, to distinguish 5-methylcytosine from 5-hydroxymethylcytosine (Booth et al., Reference Booth, Ost, Beraldi, Bell, Branco, Reik and Balasubramanian2013).
Additional work is certainly necessary to causally link these maltreatment-induced changes (and of course other epigenetic changes that are presumably occurring) with behavior. Relevant to this Special Issue is the question of how these changes might relate to attachment. Infant attachment security is heavily influenced by environmental factors (e.g., Bokhorst et al., Reference Bokhorst, Bakermans-Kranenburg, Pasco Fearon, van IJzendoorn, Fonagy and Schuengel2003; Dozier, Stoval, Albus, & Bates, Reference Dozier, Stoval, Albus and Bates2001; Roisman & Fraley, Reference Roisman and Fraley2008); thus, critical variables like parental stimulation and sensitivity (or the lack thereof) could become embedded in DNA methylation levels, including that of Bdnf, which in turn influences gene activity, neural development, synapse maturation, and circuitry function supporting caregiver–infant attachment. It is plausible that sustained changes would also contribute to disorganized and insecure attachments often seen in adults with a history of maltreatment (Riggs, Cusimano, & Benson, Reference Riggs, Cusimano and Benson2011; Shah, Fonagy, & Strathearn, Reference Shah, Fonagy and Strathearn2010; Styron & Janoff-Bulman, Reference Styron and Janoff-Bulman1997).
Further, changes in DNA methylation may be a mechanism by which caregiver-based interventions exert their beneficial effects on attachment organization. While clinical studies have demonstrated the deleterious effects of insecure and disorganized infant–caregiver attachment, including altered hypothalamus–pituitary–adrenal axis, brain development, and behavioral and emotional responses to stress (Bernard et al., Reference Bernard, Dozier, Bick, Lewis-Morrarty, Lindhiem and Carlson2012; Berthelot et al., Reference Berthelot, Ensink, Bernazzani, Normandin, Luyten and Fonagy2015; Fisher, Gunnar, Dozier, Bruce, & Pears, Reference Fisher, Gunnar, Dozier, Bruce and Pears2006; Lowell, Renk, & Adgate, Reference Lowell, Renk and Adgate2014; Lyons-Ruth, Prchtel, Yoon, Anderson, & Teicher, Reference Lyons-Ruth, Pechtel, Yoon, Anderson and Teicher2016; Pickreign Stronach et al., Reference Pickreign Stronach, Toth, Rogosch, Oshri, Manly and Cicchetti2011), caregiver-based interventions can alter attachment organization and change these outcomes (Bernard et al., Reference Bernard, Dozier, Bick, Lewis-Morrarty, Lindhiem and Carlson2012; Cicchetti, Rogosch, & Toth, Reference Cicchetti, Rogosch and Toth2006; Fisher et al., Reference Fisher, Gunnar, Dozier, Bruce and Pears2006). It is likely that methylation of DNA associated with the Bdnf gene and many others are responsive to these interventions, and altering methylation could drive changes in gene activity and neural circuitry necessary to promote a behavioral change. Studies that examine methylation pre- and postintervention are critical to elucidate the role of methylation/demethylation in conferring phenotypic change, including attachment.
In summary, our data here of the neuronal-specific nature of Bdnf methylation changes contribute to a growing understanding of the capacity of maltreatment to have long-term consequences at the molecular and cellular levels. As we continue to unravel the link between DNA methylation and phenotype, understanding the complexity and specificity of epigenetic changes brought about by early-life caregiving is an important step toward understanding the link between early-life stress and psychopathology.